Liver disease a major cause of illness and death across the EU: action needed to save lives
Tenofovir and 3TC prevent new hepatitis B infections in gay men living with HIV
Drinking coffee halves the risk of liver cancer
Dually active antiretroviral therapy protects against hepatitis B infection
Triple trouble: infection with hepatitis B increases risk of death for people with HIV and hepatitis C co-infection
Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV
Hepatitis B treatment and care in the UK need to evolve to keep pace with the global epidemic
Liver cancer has a more aggressive disease course in HIV-positive people co-infected with viral hepatitis
Adding pegylated interferon to entecavir improves hepatitis B treatment response
